Advanced search
Publication Cover
International Journal of Hyperthermia Volume 34, 2018 - Issue 8
Submit an article Journal homepage
2,911
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Prognostic scores for colorectal cancer with peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

M. EnbladDepartment of Surgical Sciences, Section of Surgery, Uppsala University, Akademiska Sjukhuset, Uppsala, 75185, SwedenView further author information
,
L. GhanipourDepartment of Surgical Sciences, Section of Surgery, Uppsala University, Akademiska Sjukhuset, Uppsala, 75185, SwedenView further author information
&
P. H. CashinDepartment of Surgical Sciences, Section of Surgery, Uppsala University, Akademiska Sjukhuset, Uppsala, 75185, SwedenCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-3474-9450View further author information
ORCID Icon
Pages 1390-1395 | Received 15 Mar 2018, Accepted 10 Apr 2018, Published online: 25 Apr 2018

References

  • Goéré D, Malka D, Tzanis D, et al. Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg. 2013;257:1065–1071.
  • Cashin PH, Dranichnikov F, Mahteme H. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy treatment of colorectal peritoneal metastases: Cohort analysis of high volume disease and cure rate. J Surg Oncol. 2014;110:203–206.
  • Cashin PH, Mahteme H, Spång N, et al. Cytoreductive surgery and intraperitoneal chemotherapy vs. systemic chemotherapy for colorectal peritoneal metastases: a randomised trial. Eur J Cancer. 2016;53:155–162.
  • Elias D, Lefevre JH, Chevalier J, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol. 2009;27:681–685.
  • Franko J, Ibrahim Z, Gusani NJ, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis. Cancer. 2010;116:3756–3762.
  • Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737–3743.
  • Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010;28:63–68.
  • Cashin PH, Graf W, Nygren P, et al. Patient selection for cytoreductive surgery in colorectal peritoneal carcinomatosis using serum tumor markers: an observational cohort study. Ann Surg. 2012;256:1078–1083.
  • Cashin PH, Graf W, Nygren P, et al. Comparison of prognostic scores for patients with colorectal cancer peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2013;20:4183–4189.
  • Chua TC, Morris DL, Esquivel J. Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2010;17:1330–1336.
  • Simkens GA, van Oudheusden TR, Nieboer D, et al. Development of a prognostic nomogram for patients with peritoneally metastasized colorectal cancer treated with cytoreductive surgery and HIPEC. Ann Surg Oncol. 2016;23:4214–4221.
  • Demey K, Wolthuis A, de Buck van Overstraeten A, et al. External validation of the prognostic nomogram (COMPASS) for patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2017;24:3604–3608.
  • Kozman MA, Fisher OM, Rebolledo BJ, et al. CEA to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with colorectal cancer peritoneal carcinomatosis undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study. J Surg Oncol. 2018;117:725–736.
  • Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221:29–42.
  • Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996; 82:359–374.
  • Egenvall M, Mörner M, Martling A, et al. Prediction of outcome after curative surgery for colorectal cancer: preoperative haemoglobin, C-reactive protein and albumin. Colorectal Dis. 2018;20:26–34.
  • Haruki K, Shiba H, Horiuchi T, et al. Impact of the C-reactive protein to albumin ratio on long-term outcomes after hepatic resection for colorectal liver metastases. Am J Surg. 2017;214:752–756.
  • Long Y, Wang T, Gao Q, et al. Prognostic significance of pretreatment elevated platelet count in patients with colorectal cancer: a meta-analysis. Oncotarget. 2016;7:81849–81861.
  • Esquivel J, Chua TC, Stojadinovic A, et al. Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study. J Surg Oncol. 2010;102:565–570.
  • Marmor RA, Kelly KJ, Lowy AM, et al. Laparoscopy is safe and accurate to evaluate peritoneal surface metastasis prior to cytoreductive surgery. Ann Surg Oncol. 2016;23:1461–1467.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.